Bipartisan House Ethics Committee Votes to Reauthorize Investigation into Collins’ Insider Trading Crimes
In case you missed it, the House Ethics Committee voted unanimously Friday to reauthorize investigations into Chris Collins.
Collins, who was indicted on 13 counts of securities fraud, wire fraud and making false statements to investigators, will be investigated by a jury of his colleagues before facing a jury of his peers next February.
The indictment is tied to securities of an Australian biotechnology company, where the Congressman has served on the board of directors. Collins gained personally and provided nonpublic information to his son Cameron Collins, who sold nearly $1.4 million of Innate Immunotherapeutics shares, according to the SEC.
“Collins brazenly and unapologetically abused his position for personal gain. This is the exact kind of behavior New Yorkers hate most about Washington politicians. He’s been booted from key committees and as a result, cannot effectively fulfill the job the people of New York elected him to do. His days in Congress are numbered,” said DCCC Spokesperson Christine Bennett.
###